Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Antivirus immune activity in multiple sclerosis correlates with MRI activity.
Combinations of susceptibility genes are associated with higher risk for multiple sclerosis and imply disease course specificity.
Inflammation, Iron, Energy Failure, and Oxidative Stress in the Pathogenesis of Multiple Sclerosis.
Ubiquitous Over-Expression of Chromatin Remodeling Factor SRG3 Ameliorates the T Cell-Mediated Exacerbation of EAE by Modulating the Phenotypes of both Dendritic Cells and Macrophages.
Application of human induced pluripotent stem cells for modeling and treating neurodegenerative diseases.
Acrolein detection: potential theranostic utility in multiple sclerosis and spinal cord injury.
The membrane attack complex of complement causes severe demyelination associated with acute axonal injury.
Fully automated open-source lesion mapping of T2-FLAIR images with FSL correlates with clinical disability in MS.
Cannabinoids: Medical implications.
Treatment of optic neuritis with erythropoietin (TONE): a randomised, double-blind, placebo-controlled trial-study protocol.
The potential role of pharmacogenomics in the prevention of serious adverse drug reactions in multiple sclerosis.
Efficacy of the ANAM General Neuropsychological Screening battery (ANAM GNS) for Detecting Neurocognitive Impairment in a Mixed Clinical Sample.
Does giving segmental muscle vibration alter the response to botulinum toxin injections in the treatment of spasticity in people with multiple sclerosis? A single-blind randomized controlled trial.
Enriched CD161high CCR6+ γδ T cells in the cerebrospinal fluid of patients with multiple sclerosis.
Serum uric acid levels and their correlation with clinical and cerebrospinal fluid parameters in patients with neuromyelitis optica.
Subacute sclerosing panencephalitis presenting as neuromyelitis optica.
Genome-wide association studies: will we ever predict susceptibility to multiple sclerosis through genetics?
[Therapeutic options for autoimmune encephalomyelitis].
Vitamin D supplementation, moderate sun exposure, and control of immune Diseases.
Mortality in patients with multiple sclerosis.
Cognitive functions in multiple sclerosis: impact of gray matter integrity.
Elevated levels of PPAR-gamma in the cerebrospinal fluid of patients with multiple sclerosis.
Burden of disease in multiple sclerosis patients with spasticity in Germany: mobility improvement study (Move I).
Tregitope Peptides: The Active Pharmaceutical Ingredient of IVIG?
Morphometric and quantitative immunohistochemical analysis of disease-related changes in the upper (suburothelial) lamina propria of the human bladder dome.
Pages
« first
‹ previous
…
460
461
462
463
464
465
466
467
468
…
next ›
last »